# OnCo record lenograstim (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/lenograstim/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "lenograstim" ;
  schema:name "Lenograstim"@en ;
  schema:alternateName "rHuG-CSF (glycosylated)"@en, "Granocyte" ;
  schema:description "Lenograstim is Europe's and Japan's glycosylated form of G-CSF, given after chemotherapy to shorten the period of dangerously low neutrophils and to mobilise stem cells for transplant; it does the same job as filgrastim."@en ;
  schema:url <https://onco.cc/drugs/lenograstim/> ;
  schema:dateModified "2026-09-08"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Lenograstim> ;
  schema:citation <https://en.wikipedia.org/wiki/Lenograstim>, <https://www.ebi.ac.uk/chembl/explore/compound/CHEMBL1201567> ;
  onco:status "established" ;
  onco:tag "gap-fill", "chembl-universe" ;
  onco:modality "Recombinant glycosylated G-CSF, injection" ;
  onco:technologies <https://onco.cc/technologies/cytokine-therapy/> ;
  onco:targets <https://onco.cc/targets/csf3r/> ;
  onco:drugs <https://onco.cc/drugs/filgrastim/>, <https://onco.cc/drugs/pegfilgrastim/> ;
  onco:companies <https://onco.cc/companies/chugai/> ;
  onco:trials <https://onco.cc/trials/nct01985724/>, <https://onco.cc/trials/nct00615602/>, <https://onco.cc/trials/nct00431080/> .